Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, has strengthened its market position in Canada with the grant of three new patents. The company has also received an additional Natural Products Number (NPN) issued by Health Canada, bringing their total number of products with health claims in Canada to 37.

Read more ...

Disruptions from the COVID-19 pandemic have caused hardship across the world, with the poorest people in India hit particularly hard. With the objective of helping to alleviate food insecurity, the Dr. Majeed Foundation gave 5,500 rice bags of 10 kilo each to the people of Magadi, Karnataka on September 24, 2020. The Foundation is the philanthropic organization started and funded by the Sami-Sabinsa Group founder and chairman, Dr. Muhammed Majeed.

Read more ...

Sabinsa, the leading nutraceutical ingredients company with patents throughout the world, has expanded its portfolio of intellectual property with a new patent granted in Mexico for Saberry^®.

Read more ...

A clinical study on Sabinsa’s patented hair serum formulation was found to significantly improve hair fall and thinning. “Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall” by Majeed M, Majeed S, Nagabhushanam K, Mundkur L, Neupane P and Shah K was published in Clinical, Cosmetic and Investigational Dermatology (2020:13 691–700).

Read more ...

Additional In Vitro Study Examined Anti-Aging Properties

As Sabinsa’s R&D Scientists expanded their understanding of probiotics, and developed new products based upon that increased knowledge, it was inevitable that published studies would soon follow. Sabinsa has recently published its first human clinical study on anti-acne benefits of LactoSporin^®, the probiotic metabolite derived from the highly regarded probiotic LactoSpore^®. A second published study, in vitro, demonstrated the anti-aging potential of this topical ingredient. Together, the research supports the use of LactoSporin for skin care applications.

Read more ...

Sabinsa has sent a cease & desist letter to Applied Food Sciences (AFS) for making claims of high levels of natural vitamin C in that company’s branded amla (Emblica officinalis) extract. The letter states that AFS’s representations that the product contains 25% vitamin C derived from amla (which is not technically possible) “mislead and deceive consumers and constitute unfair competition and false advertising under applicable law.”

Read more ...

Sabinsa, the pioneer of ingredients conceived by modern science drawing from traditional Ayurvedic knowledge, announces a new combination to support healthy liver function, LivLonga^®, giving a boost to a category teeming with dated, generic products.

Read more ...

Sabinsa is pleased to announce that several of the company’s ingredients have been Non-GMO Project Verified, adding to the value the end-user finds in Sabinsa’s transparency and commitment to natural, sustainable, and Non-GMO ingredients.

Read more ...

Sabinsa’s Curcumin C3 Complex^®, the #1 clinically studied curcumin brand on the market, is the subject of a recently published study on its effect, combined with BioPerine^®, on serum cytokine concentrations. Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double-blind placebo-controlled trial was published in the peer-reviewed journal Phytotherapy Research.

Read more ...

Sabinsa founder and chairman Dr. Muhammed Majeed presents check to PM CARES Fund.
From Left to Right: Ms. Neeraja Shetty, CEO and Director, Sami Labs; Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group; Dr. Anju Majeed, Director and Sr. Scientist, Sami Labs; and Shaheen Majeed, President Worldwide, Sabinsa and Director, Sami Labs

Read more ...